Dr Reddy’s announces commercialisation of Vozet in India

Views: 57

Hyderabad, July 18 (IANS) Pharma major Dr Reddy’s Laboratories on Tuesday announced the commercialisation of Vozet tablets in India, used for the treatment of allergic Rhinitis and chronic Urticaria.

The Vozet tablets contain Levocetirizine 5 mg, and are available in a strip size of 10, the Hyderabad-headquartered company said in a statement.

The anti-histamine market in India had sales of Rs 1,038 crore MAT (Moving Annual Total) for the most recent 12 months ended March 2017, according to information technology company for the healthcare industry IMS ORG.

Dr Reddy’s will further strengthen its anti-allergy portfolio with the addition of Vozet, said the statement.



ALSO READ:   Kenyan alleges gang rape in Gurugram, three detained
Comments: 0

Your email address will not be published. Required fields are marked with *